Vnitr Lek 2005, 51(9):1042-1044

Redakční pošta

L. Smolej
Oddělení klinické hematologie II. interní kliniky Lékařské fakulty UK aFN, Hradec Králové, přednosta prof. MUDr. Jaroslav Malý, CSc.

Received: April 14, 2005; Published: September 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Smolej L. Redakční pošta. Vnitr Lek. 2005;51(9):1042-1044.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Deutsche CLL Studiengruppe. Studienübersicht der DCLLSG. www.dcllsg.de
    2. Frewin R, Turner D, Tighe M et al. Combination therapy with fludarabine and cyclophosphamide as salvage treatment in lymphoproliferative disorders. Br J Haematol 1999; 104: 612-613. Go to original source... Go to PubMed...
    3. Hallek M, Schmitt B, Wilhelm M et al. Fludarabine plus cyclophosphamide are an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. Br J Haematol. 2001; 114: 342-348. Go to original source... Go to PubMed...
    4. Montillo M, Hamblin T, Hallek M et al. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. Haematologica 2005; 90: 391-399. Go to PubMed...
    5. Moreton P, Kennedy B, Lucas G et al. Eradication of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia After Alemtuzumab Therapy Is Associated With Prolonged Survival. J Clin Oncol 2005; 23: 2971-2979. Go to original source... Go to PubMed...
    6. NICE. Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia. Technology Appraisal Guidance - No. 29, 2001.
    7. O'Brien SM, Kantarjian HM, Cortes J et al. Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. J Clin Oncol 2001; 19: 1414-1420. Go to original source... Go to PubMed...
    8. Rawstron AC, Kennedy B, Evans PA et al. Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy. Blood 2001; 98: 29-35. Go to original source... Go to PubMed...
    9. Shanafelt T, Geyer S, Kay N. Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 2004; 103: 1202-1210. Go to original source... Go to PubMed...
    10. Sturm I, Bosanquet AG, Hermann S et al. Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy. Cell Death Differ 2003; 10: 477-484. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.